News

2020/06/11
The June 2020 issue of Industry Era, a U.S. technology magazine, featured Gemseki President and CEO, Hideyuki Hirama as…
2020/06/08
On June 1, 2020, NIKKEI xTECH, a leading Japanese economic magazine, published an article entitled “61 companies…
2020/05/25
Gemseki has joined the Open COVID-19 Declaration, to provide our services and know-how to combat COVID-19 around the…
2020/05/11
Gemseki has decided to join the global initiative, Open COVID Pledge, to provide our services and know-how to combat…
2020/04/01
In accordance with the Gemseki declaration on COVID-19 as of March 30th, Gemseki has decided to offer free partnering…
2020/03/30
Gemseki declares and commits to deliver effective treatments for diseases including COVID-19 through licensing and…
2019/10/16
Hideyuki Hirama, President and CEO, made a presentation at “Latest Trend in Advanced Therapy and Biomedical Engineering…
2019/09/30
New Leader, a monthly comprehensive economic magazine in Japan for future generations, featured Gemseki in its series “…
2019/09/09
Gemseki has been selected as one of the Top 10 Drug Discovery Consulting/Services Companies in APAC 2019 by Pharma Tech…
2019/08/16
Hideyuki Hirama, President and CEO, was invited to make a presentation at China (Rizhao) Biomedical Industry…